KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Receivables (2016 - 2026)

Staar Surgical (STAA) has disclosed Receivables for 17 consecutive years, with $50.4 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Receivables fell 52.23% year-over-year to $50.4 million, compared with a TTM value of $50.4 million through Jan 2026, down 52.23%, and an annual FY2026 reading of $50.4 million, down 52.23% over the prior year.
  • Receivables was $50.4 million for Q1 2026 at Staar Surgical, down from $60.1 million in the prior quarter.
  • Across five years, Receivables topped out at $112.4 million in Q3 2023 and bottomed at $34.4 million in Q2 2025.
  • Average Receivables over 5 years is $71.6 million, with a median of $63.2 million recorded in 2022.
  • The sharpest move saw Receivables skyrocketed 102.72% in 2023, then plummeted 63.28% in 2025.
  • Year by year, Receivables stood at $62.5 million in 2022, then soared by 51.9% to $94.9 million in 2023, then increased by 11.1% to $105.4 million in 2024, then plummeted by 42.99% to $60.1 million in 2025, then fell by 16.2% to $50.4 million in 2026.
  • Business Quant data shows Receivables for STAA at $50.4 million in Q1 2026, $60.1 million in Q3 2025, and $34.4 million in Q2 2025.